The patient health questionnaire-9: validation among patients with glaucoma.
BACKGROUND: Depression and anxiety are two common normal responses to a chronic disease such as glaucoma. This study analysed the measurement properties of the depression screening instrument - Patient Health Questionnaire-9 (PHQ-9) using Rasch analysis to determine if it can be used as a measure. M...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4085058?pdf=render |
id |
doaj-6b9a1186101f44849ced2a14f22cd361 |
---|---|
record_format |
Article |
spelling |
doaj-6b9a1186101f44849ced2a14f22cd3612020-11-25T01:18:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0197e10129510.1371/journal.pone.0101295The patient health questionnaire-9: validation among patients with glaucoma.Vijaya K GothwalDeepak K BaggaSeelam BharaniRebecca SumaliniShailaja P ReddyBACKGROUND: Depression and anxiety are two common normal responses to a chronic disease such as glaucoma. This study analysed the measurement properties of the depression screening instrument - Patient Health Questionnaire-9 (PHQ-9) using Rasch analysis to determine if it can be used as a measure. METHODS: In this hospital-based cross-sectional study, the PHQ-9 was administered to primary glaucoma adults attending a glaucoma clinic of a tertiary eye care centre, South India. All patients underwent a comprehensive clinical evaluation. Patient demographics and sub-type of glaucoma were abstracted from the medical record. Rasch analysis was used to investigate the following properties of the PHQ-9: behaviour of the response categories, measurement precision (assessed using person separation reliability, PSR; minimum recommended value 0.80), unidimensionality (assessed using item fit [0.7-1.3] and principal components analysis of residuals), and targeting. RESULTS: 198 patients (mean age ± standard deviation = 59.83±12.34 years; 67% male) were included. The native PHQ-9 did not fit the Rasch model. The response categories showed disordered thresholds which became ordered after category reorganization. Measurement precision was below acceptable limits (0.62) and targeting was sub-optimal (-1.27 logits). Four items misfit that were deleted iteratively following which a set of five items fit the Rasch model. However measurement precision failed to improve and targeting worsened further (-1.62 logits). CONCLUSIONS: The PHQ-9, in its present form, provides suboptimal assessment of depression in patients with glaucoma in India. Therefore, there is a need to develop a new depression instrument for our glaucoma population. A superior strategy would be to use the item bank for depression but this will also need to be validated in glaucoma patients before deciding its utility.http://europepmc.org/articles/PMC4085058?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vijaya K Gothwal Deepak K Bagga Seelam Bharani Rebecca Sumalini Shailaja P Reddy |
spellingShingle |
Vijaya K Gothwal Deepak K Bagga Seelam Bharani Rebecca Sumalini Shailaja P Reddy The patient health questionnaire-9: validation among patients with glaucoma. PLoS ONE |
author_facet |
Vijaya K Gothwal Deepak K Bagga Seelam Bharani Rebecca Sumalini Shailaja P Reddy |
author_sort |
Vijaya K Gothwal |
title |
The patient health questionnaire-9: validation among patients with glaucoma. |
title_short |
The patient health questionnaire-9: validation among patients with glaucoma. |
title_full |
The patient health questionnaire-9: validation among patients with glaucoma. |
title_fullStr |
The patient health questionnaire-9: validation among patients with glaucoma. |
title_full_unstemmed |
The patient health questionnaire-9: validation among patients with glaucoma. |
title_sort |
patient health questionnaire-9: validation among patients with glaucoma. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
BACKGROUND: Depression and anxiety are two common normal responses to a chronic disease such as glaucoma. This study analysed the measurement properties of the depression screening instrument - Patient Health Questionnaire-9 (PHQ-9) using Rasch analysis to determine if it can be used as a measure. METHODS: In this hospital-based cross-sectional study, the PHQ-9 was administered to primary glaucoma adults attending a glaucoma clinic of a tertiary eye care centre, South India. All patients underwent a comprehensive clinical evaluation. Patient demographics and sub-type of glaucoma were abstracted from the medical record. Rasch analysis was used to investigate the following properties of the PHQ-9: behaviour of the response categories, measurement precision (assessed using person separation reliability, PSR; minimum recommended value 0.80), unidimensionality (assessed using item fit [0.7-1.3] and principal components analysis of residuals), and targeting. RESULTS: 198 patients (mean age ± standard deviation = 59.83±12.34 years; 67% male) were included. The native PHQ-9 did not fit the Rasch model. The response categories showed disordered thresholds which became ordered after category reorganization. Measurement precision was below acceptable limits (0.62) and targeting was sub-optimal (-1.27 logits). Four items misfit that were deleted iteratively following which a set of five items fit the Rasch model. However measurement precision failed to improve and targeting worsened further (-1.62 logits). CONCLUSIONS: The PHQ-9, in its present form, provides suboptimal assessment of depression in patients with glaucoma in India. Therefore, there is a need to develop a new depression instrument for our glaucoma population. A superior strategy would be to use the item bank for depression but this will also need to be validated in glaucoma patients before deciding its utility. |
url |
http://europepmc.org/articles/PMC4085058?pdf=render |
work_keys_str_mv |
AT vijayakgothwal thepatienthealthquestionnaire9validationamongpatientswithglaucoma AT deepakkbagga thepatienthealthquestionnaire9validationamongpatientswithglaucoma AT seelambharani thepatienthealthquestionnaire9validationamongpatientswithglaucoma AT rebeccasumalini thepatienthealthquestionnaire9validationamongpatientswithglaucoma AT shailajapreddy thepatienthealthquestionnaire9validationamongpatientswithglaucoma AT vijayakgothwal patienthealthquestionnaire9validationamongpatientswithglaucoma AT deepakkbagga patienthealthquestionnaire9validationamongpatientswithglaucoma AT seelambharani patienthealthquestionnaire9validationamongpatientswithglaucoma AT rebeccasumalini patienthealthquestionnaire9validationamongpatientswithglaucoma AT shailajapreddy patienthealthquestionnaire9validationamongpatientswithglaucoma |
_version_ |
1725141345563049984 |